Q2049 Imported lipodox injection
Also known as: Doxil, liposomal doxorubicin, pegylated liposomal doxorubicin
Imported liposomal doxorubicin injection, a chemotherapy drug delivered in liposomal formulation for improved distribution and reduced cardiotoxicity.
In Plain Language
cancer chemotherapy; IV chemotherapy
Clinical Context
Used for Kaposi sarcoma, ovarian cancer, and breast cancer. Liposomal formulation reduces cardiotoxicity compared to conventional doxorubicin.
RVU Information
CPT Q2049 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q2049?
CPT Q2049 (Imported lipodox injection) is a Q Codes code. Imported liposomal doxorubicin injection, a chemotherapy drug delivered in liposomal formulation for improved distribution and reduced cardiotoxicity.
Is Q2049 covered by insurance?
Q2049 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for Kaposi sarcoma, ovarian cancer, and breast cancer. Liposomal formulation reduces cardiotoxicity compared to conventional doxorubicin.
When is CPT Q2049 used?
Used for Kaposi sarcoma, ovarian cancer, and breast cancer. Liposomal formulation reduces cardiotoxicity compared to conventional doxorubicin.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.